Bsenexus Terminal Open in Bsenexus App →
OTHER

Neuland Laboratories Limited

Neuland Laboratories Limited has informed the Exchange regarding 'We refer to our letter dated August 14, 2026 regarding the US FDA inspection conducted at our Unit 3 manufacturing facility and would like to inform that the US FDA has issued an EIR against the inspection conducted from August 10, 2026 to August 14, 2026. The US FDA has concluded that this inspection is closed.

Filing Details / Description
Updates - Neuland Laboratories Limited has informed the Exchange regarding 'We refer to our letter dated August 14, 2026 regarding the US FDA inspection conducted at our Unit 3 manufacturing facility and would like to inform that the US FDA has issued an EIR against the inspection conducted from August 10, 2026 to August 14, 2026. The US FDA has concluded that this inspection is closed.
🔗 Related Announcements 5 Disclosures
Max India Ltd OTHER
Max India Ltd - 543223 - Execution Of Letter Of Comfort In Favour Of Aditya Birla Capital Limited
SIS Ltd OTHER
SIS Ltd - 540673 - Announcement under Regulation 30 (LODR)-Daily Buy Back of equity shares
String Metaverse Ltd OTHER
String Metaverse Ltd - 534535 - Announcement under Regulation 30 (LODR)-Preferential Issue
Nitco Limited OTHER
Nitco Limited has informed the Exchange about update on transaction with M/s. R Siddhatva Developers Private Limited, a step-down subsidiary of M/s. Runwal Construction Private Limited
Thomas Cook (India) Limited OTHER
Thomas Cook (India) Limited has informed the Exchange about voluntary dissolution of its stepdown subsidiary Digiphoto Entertainment Imaging INC in Canada.
📄 View Official BSE Filing (PDF) ↗ Explore Live BSE Corporate Disclosures on Bsenexus →